Breast Cancer Canada and REAL Alliance Release National Breast Cancer Care Recommendations

What the New National Recommendations Mean for Canadians

Breast Cancer Canada and the REAL Canadian Breast Cancer Alliance have just released a joint set of national recommendations. The goal is simple: streamline care, close gaps in access, and give every Canadian diagnosed with breast cancer a clear, evidence‑based pathway from screening to survivorship.

Why a unified set of guidelines is needed

• Geographic disparities: Rural and northern communities often wait longer for diagnostic imaging and specialist appointments.
• Inconsistent protocols: Different provinces use varying screening ages and follow‑up schedules, creating confusion for patients and providers.
• Rapid advances in treatment: New targeted therapies and immunotherapies require coordinated implementation across the health system.

Key Recommendations

1. Standardized screening ages: Begin routine mammography at age 40 for high‑risk women and at age 50 for average‑risk women, with a biennial interval nationwide.
2. Fast‑track diagnostic pathways: Guarantee a diagnostic mammogram, ultrasound, or MRI within 14 days of an abnormal screening result.
3. Equal access to multidisciplinary care: Every patient should be reviewed by a breast cancer team—including surgery, medical oncology, radiation oncology, pathology, genetics, and psychosocial support—within 21 days of diagnosis.
4. National formulary for targeted therapies: Ensure HER2‑positive, triple‑negative and BRCA‑mutated cancers have uniform drug coverage across provinces.
5. Survivorship and mental‑health planning: Incorporate survivorship care plans, fertility counselling, and mental‑health services as mandatory components of treatment.
6. Data‑driven quality improvement: Create a Canadian Breast Cancer Registry that tracks outcomes, treatment timelines, and patient‑reported experience measures.

How the Recommendations Will Be Implemented

The two organizations will work with provincial health ministries, the Canadian Partnership Against Cancer, and patient advocacy groups to roll out a phased implementation plan:

• Phase 1 (2024‑2025): Align screening protocols and set up fast‑track diagnostic hubs in high‑need regions.
• Phase 2 (2025‑2026): Deploy the multidisciplinary team model and national drug formulary.
• Phase 3 (2026‑2027): Launch the national registry and integrate survivorship programs into community health centres.

What Patients Can Do Right Now

• Know your risk: discuss family history and genetic testing with your primary care provider.
• Schedule regular mammograms according to the new age guidelines.
• If you receive an abnormal result, ask for a clear timeline—diagnostic imaging should be done within two weeks.
• Ask to be referred to a multidisciplinary breast cancer team; it’s a core part of the recommendation.
• Seek support services early—counselling, fertility preservation, and survivorship resources are now considered essential care.

Conclusion

The joint recommendations from Breast Cancer Canada and the REAL Canadian Breast Cancer Alliance signal a major step toward equity, speed, and quality in breast‑cancer care across the country. By standardising screening, guaranteeing rapid diagnostics, and making comprehensive treatment and survivorship support mandatory, Canada moves closer to a future where every patient receives the best possible outcome, no matter where they live.